Bausch + Lomb Announces 2023 Annual Meeting of Shareholder Results

Rhea-AI Summary

Bausch + Lomb Corporation (NYSE/TSX: BLCO) held its 2023 annual meeting on April 24, 2023, where shareholders elected 10 directors. Key voting results included:

• Nathalie Bernier: 344,100,848 votes for, 124,733 against
• Richard U. De Schutter: 344,094,979 votes for, 130,602 against
• Gary Hu: 344,016,782 votes for, 208,799 against
• Brett Icahn: 344,072,707 votes for, 152,874 against

In addition to the elections, shareholders approved the advisory compensation of executives, an amendment to increase shares under the 2022 Omnibus Incentive Plan, and appointed PricewaterhouseCoopers LLP as the independent accounting firm until the 2024 annual meeting. The results will be filed with the SEC.

Positive

• Shareholders elected 10 directors with substantial majority votes.
• Compensation for executive officers received shareholder approval.
• The amendment to the Omnibus Incentive Plan increases shares available, enhancing employee incentives.

Negative

• Thomas W. Ross faced significant opposition with 4,014,230 votes against.

VAUGHAN, Ontario--(BUSINESS WIRE)-- Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb” or the “Company”), a leading global eye health company dedicated to helping people see better to live better, today announced the election of the 10 directors nominated at its 2023 annual meeting of shareholders (the “Annual Meeting”) held on April 24, 2023. The detailed results of the vote for the election of directors are set out below:

Name		For		Against		Broker Non-Votes
Nathalie Bernier		344,100,848		124,733		2,315,925
Richard U. De Schutter		344,094,979		130,602		2,315,925
Gary Hu		344,016,782		208,799		2,315,925
Brett Icahn		344,072,707		152,874		2,315,925
Sarah B. Kavanagh		343,989,666		235,915		2,315,925
John A. Paulson		344,095,439		130,142		2,315,925
Russel C. Robertson		344,098,056		127,525		2,315,925
Thomas W. Ross, Sr.		340,211,351		4,014,230		2,315,925
Brenton L. Saunders		342,408,245		1,817,336		2,315,925
Andrew C. von Eschenbach, M.D.		343,985,915		239,666		2,315,925

At the Annual Meeting, shareholders also approved, in a non-binding advisory vote, the compensation of the Company’s named executive officers and the frequency of future advisory votes on named executive officer compensation being one year, approved an amendment and restatement of the Company’s 2022 Omnibus Incentive Plan (the “Plan”) to increase the number of common shares authorized for issuance thereunder, and appointed PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm until the close of the Company's 2024 annual meeting of shareholders.

For the purposes of Toronto Stock Exchange (“TSX”) approval with respect to the Plan, the Company relied on the exemption set forth in Section 602.1 of the TSX Company Manual, which provides that the TSX will not apply its standards to certain transactions involving eligible inter-listed issuers on a recognized exchange, such as the NYSE.

The final vote tabulation on all matters voted on at the Annual Meeting will be filed with the U.S. Securities and Exchange Commission on a current report on Form 8-K, and such report will be made available on the Company's SEDAR profile and on the Company’s website at www.bausch.com.

About Bausch + Lomb
Bausch + Lomb is dedicated to protecting and enhancing the gift of sight for millions of people around the world – from the moment of birth through every phase of life. Its comprehensive portfolio of more than 400 products includes contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products and ophthalmic surgical devices and instruments. Founded in 1853, Bausch + Lomb has a significant global research and development, manufacturing and commercial footprint with approximately 13,000 employees and a presence in nearly 100 countries. Bausch + Lomb is headquartered in Vaughan, Ontario with corporate offices in Bridgewater, New Jersey. For more information, visit www.bausch.com and connect with us on Twitter, LinkedIn, Facebook and Instagram.

© 2023 Bausch & Lomb Incorporated or its affiliates.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230425005469/en/

Investors:

Arthur Shannon

arthur.shannon@bausch.com

Allison Ryan

allison.ryan@bausch.com

(877) 354-3705 (toll free)

(908) 927-0735

Media:

Lainie Keller

lainie.keller@bausch.com

(908) 927-1198

Source: Bausch + Lomb Corporation

FAQ

What happened at Bausch + Lomb's annual meeting on April 24, 2023?

At the annual meeting, Bausch + Lomb shareholders elected 10 directors and approved executive compensation.

What was the outcome of the director elections for BLCO on April 24, 2023?

All 10 nominated directors were elected with significant majority votes.

Who were the directors elected at Bausch + Lomb's 2023 annual meeting?

Directors elected included Nathalie Bernier, Richard U. De Schutter, Gary Hu, and others.

Did Bausch + Lomb's shareholders approve the compensation of executive officers?

Yes, shareholders approved the compensation of the Company’s named executive officers.

What is the significance of the 2022 Omnibus Incentive Plan amendment for BLCO?

The amendment increases the number of shares authorized for issuance, providing more incentives for employees.